Follow
Christine Desmedt
Christine Desmedt
Verified email at kuleuven.be
Title
Cited by
Cited by
Year
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
nature 500 (7463), 415-421, 2013
103882013
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
23612006
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
23232016
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
19482012
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
13942014
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
10982013
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
10972007
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10, 1-11, 2008
10572008
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ...
Clinical cancer research 14 (16), 5158-5165, 2008
9582008
Definition of clinically distinct molecular subtypes in estrogen receptor–positive breast carcinomas through genomic grade
S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ...
Journal of clinical oncology 25 (10), 1239-1246, 2007
9482007
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751-759, 2015
8632015
Genomic evolution of breast cancer metastasis and relapse
LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ...
Cancer cell 32 (2), 169-184. e7, 2017
6932017
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
A Bassez, H Vos, L Van Dyck, G Floris, I Arijs, C Desmedt, B Boeckx, ...
Nature medicine 27 (5), 820-832, 2021
4922021
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 1251343, 2014
4582014
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ...
BMC genomics 9, 1-12, 2008
4282008
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ...
Nature medicine 16 (2), 214-218, 2010
4012010
A three-gene model to robustly identify breast cancer molecular subtypes
B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ...
Journal of the National Cancer Institute 104 (4), 311-325, 2012
3782012
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
3242016
Genomic index of sensitivity to endocrine therapy for breast cancer
WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ...
Journal of clinical oncology 28 (27), 4111-4119, 2010
2892010
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ...
PloS one 6 (6), e20980, 2011
2792011
The system can't perform the operation now. Try again later.
Articles 1–20